Document:

<PAGE>

                                                                     EXHIBIT 4.7

            COLLATERAL ASSIGNMENT OF NOTE AND SECURITY AGREEMENT

         THIS COLLATERAL ASSIGNMENT OF NOTE AND SECURITY AGREEMENT (this
"Assignment") is made and entered into as of the 1st day of October, 2003 (the
"Effective Date"), by ARDENT HEALTH SERVICES, INC, a Delaware corporation, with
a mailing address of One Burton Hills Boulevard, Suite 250, Nashville, Tennessee
37215 (the "Assignor"), to BANK ONE, NA, a national banking association, with a
mailing address of 416 W. Jefferson Street, PO Box 32500, Louisville, KY 40232,
in its capacity as collateral agent for the Secured Parties (the "Collateral
Agent"). All terms used but not otherwise defined herein shall have the meanings
provided in the Intercreditor Agreement (as defined below) or, if not defined
therein, in the Credit Agreement (as defined below).

                                   WITNESSETH:

         WHEREAS, the Assignor is party to that certain Credit Agreement dated
as of August 19, 2003 by and between Assignor, certain guarantors party thereto
from time to time, Bank One, NA, as administrative agent (the "Administrative
Agent") and the lenders party thereto from time to time (as amended, modified,
supplemented, extended, renewed or replaced from time to time, the "Credit
Agreement") pursuant to which the Assignor is required to (a) cause, under
certain circumstances set forth therein, each HMO Subsidiary to (i) issue an
intercompany promissory note to the Assignor or a Subsidiary in a principal
amount set forth in the Credit Agreement and (ii) grant to the Assignor or such
Subsidiary, as applicable, a security interest in certain of its real and
personal property to secure the obligations of such HMO Subsidiary under such
intercompany promissory note pursuant to the intercompany security documents
described in the Credit Agreement and (b) collaterally assign, and grant a
security interest in, all of the Assignor's or such Subsidiary's, as applicable,
rights under such intercompany promissory note and such intercompany security
documents to the Collateral Agent as collateral security for the Senior
Obligations;

         WHEREAS, pursuant to the terms of that certain Indenture dated as of
August 19, 2003 among the Assignor, certain Subsidiaries of the Assignor party
thereto, and U.S. Bank Trust National Association, as trustee (the "Trustee"),
in the event that the Assignor or any Subsidiary grants a security interest in
the Assignor's or such Subsidiary's, as applicable, rights under any such
intercompany promissory note and any such intercompany security documents to the
Collateral Agent as collateral security for the Senior Obligations, then the
Assignor or such Subsidiary, as applicable, is also required to grant a security
interest in the Assignor's or such Subsidiary's, as applicable, rights under
such intercompany promissory note and such intercompany security documents in
favor of the holders of the Subordinated Notes as collateral security for the
Subordinated Obligations;

         WHEREAS, the Assignor, the Collateral Agent, the Administrative Agent
and the Trustee have entered into that certain Intercreditor Agreement dated as
of August 19, 2003 (the "Intercreditor Agreement") to define the rights, duties,
authority and responsibilities of the

<PAGE>

Collateral Agent and the relationship among the Secured Parties regarding the
relative rights and priorities with respect to the Collateral; and

         WHEREAS, the Assignor has agreed to collaterally assign to the
Collateral Agent, all of Assignor's right, title and interest in and to the
Documents (defined below), pursuant to the terms and conditions hereof.

         NOW, THEREFORE, for and in consideration of the sum of Ten Dollars
($10.00) and other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the Assignor hereby agrees with the Collateral
Agent, as follows:

         1.       Grant of Security Interest. To secure the payment, performance
and observance of the Secured Obligations (as defined below), the Assignor does
hereby collaterally grant, bargain, sell, convey, transfer, set over, assign and
deliver to the Collateral Agent, all right, title and interest of the Assignor
in and to the documents described on Exhibit A attached hereto and made a part
hereof, the loan evidenced thereby, and all other documents pertaining thereto
(collectively, the "Documents").

         2.       As used herein, the term "Secured Obligations" means:

                  (a)      all obligations (including (a) principal, interest,
         fees, indemnities and all other amounts and (b) interest accruing after
         commencement of a proceeding in bankruptcy, reorganization or
         insolvency, whether or not allowable as a claim), contingent or
         otherwise, of the Loan Parties from time to time to the Senior
         Creditors under the Credit Documents. The foregoing shall also include
         any Swap Contract between any Loan Party and any Lender or affiliate of
         a Lender; and

                  (b)      all obligations (including (a) principal, interest,
         fees, premiums, liquidated damages, indemnities and all other amounts
         and (b) interest accruing after commencement of a proceeding in
         bankruptcy, reorganization or insolvency, whether or not allowable as a
         claim), contingent or otherwise, of the Loan Parties from time to time
         to the Subordinated Creditors under the Subordinated Note Documents.

                  3.       This assignment is absolute and effective immediately
         and without possession. Notwithstanding the foregoing, so long as there
         shall exist no Event of Default, Assignor shall have the revocable
         right (but limited as provided in the following paragraph) to collect
         upon, but not prior to, accrual, all amounts under the Documents and to
         apply the same in such manner as Assignor shall elect, which right
         shall be revoked automatically upon the occurrence of an Event of
         Default, without need of notice, possession, foreclosure or any other
         act or procedure, and all amounts due under the Documents shall
         thereafter be payable to Collateral Agent.

                  4.       In addition to the foregoing, upon the occurrence of
         an Event of Default, Collateral Agent shall have all of the rights and
         remedies of a secured party under the Uniform Commercial Code enacted
         in the State of New Mexico (as such Uniform Commercial Code may be
         amended hereafter, the "UCC"), and Collateral Agent shall be entitled
         to avail itself of all such other rights

                                       2
<PAGE>

and remedies as may now or hereafter exist at law or in equity for the
collection of the Secured Obligations and the foreclosure of the security
interest created hereby and the resort to any remedy provided hereunder, in the
Credit Documents or as provided by the UCC, or by any other applicable law, and
the exercise thereof by Collateral Agent shall not prevent the concurrent
employment of any other appropriate remedy. Upon the occurrence of an Event of
Default, the right granted pursuant to Paragraph 3 hereof shall be terminated
and Collateral Agent will be entitled to enforce all of the rights under the
Documents. Assignor agrees that it will facilitate in all reasonable ways the
enforcement of such rights.

         5.       Without limitation of any other provision of any other Credit
Document, Assignor hereby agrees to pay all costs and expenses incurred by
Collateral Agent in connection with the enforcement of this Assignment,
including, without limitation, reasonable attorneys' fees and expenses and court
costs.

         6.       Assignor shall take such further actions and shall execute
such other documents as may be necessary or as may be reasonably required by
Collateral Agent to protect or perfect the liens and security interests created
or intended to be created hereby and otherwise to complete the transactions
contemplated hereby.

         7.       Collateral Agent shall not by virtue of this Assignment be
deemed in any manner to have assumed any obligations with respect to the
Documents. Assignor agrees to indemnify and to hold Collateral Agent harmless of
any and from any and all liability, loss or damage which Collateral Agent may or
might incur by reason of any claims or demands against Collateral Agent arising
out of or in any way connected with this Assignment, unless Collateral Agent
assumes Assignor's obligations under the Documents in writing and except to the
extent that loss or damage results from Collateral Agent's gross negligence or
willful misconduct.

         8.       This Assignment shall also constitute and serve as a "Security
Agreement" within the meaning of and shall create a security interest under the
UCC to the extent applicable to the Documents. Collateral Agent shall have all
rights with respect to the Documents under the UCC in addition to the other
rights afforded to Collateral Agent by this Assignment. Assignor agrees to
execute and deliver to Collateral Agent such "Financing Statements" and other
reasonable documents and assurances which Collateral Agent may from time to time
consider necessary to perfect or continue to effect Collateral Agent's lien on
the Documents, and Assignor agrees to pay all costs of recording any such
documents.

         9.       Assignor hereby warrants and represents to Collateral Agent
that: (i) Assignor has not pledged, assigned or otherwise encumbered or disposed
of the Documents or the Assignor's rights thereunder except pursuant to this
Assignment and agrees not to do so without Collateral Agent's prior express
written consent; (ii) the Documents constitute the valid, binding and
enforceable obligations of Assignor; and (iii) to the best of Assignor's
knowledge there exists no default, nor any act, event and/or condition which
with lapse of time and/or notice would constitute a default under the Documents.

                                       3
<PAGE>

         10.      Assignor covenants and warrants that, except with the express
written consent of Collateral Agent, Assignor will not (a) change, amend, modify
or waive any term or condition of any of the Documents or (b) agree to a
compromise or any other modification of the terms of the Documents.

         11.      Assignor covenants and warrants that Assignor will comply with
the terms of the Documents.

         12.      Assignor covenants that it, within five (5) Business Days of
receipt of notice thereof, promptly notify the Collateral Agent of any reduction
in the minimum amount necessary to maintain Lovelace Health Systems, Inc.'s
compliance with minimum net worth or other applicable solvency requirements set
forth in Chapter 59A, NMSA 1978 and the regulations promulgated thereunder. Such
notice shall include an explanation regarding the reasons for the reduction and
its anticipated duration. In addition, Assignor covenants that it will within
five (5) Business Days of the receipt or giving thereof, provide the Collateral
Agent with a copy of any notice received or given by the Assignor pursuant to
the Documents.

         13.      THIS ASSIGNMENT SHALL BE CONSTRUED IN ACCORDANCE WITH THE LAWS
OF THE STATE OF NEW YORK.

         14.      Upon payment in full and complete discharge of the Secured
Obligations, this Assignment shall become and be void and of no force or effect,
and Collateral Agent shall release its lien on and security interest in the
Documents.

                [remainder of this page intentionally left blank]

                                       4
<PAGE>

         IN WITNESS WHEREOF, the Assignor and the Collateral Agent have duly
executed this Assignment under seal as of the day and year first above written.

                                    ARDENT HEALTH SERVICES, INC.
                                    a Delaware corporation

                                    By: /s/ William P. Barnes
                                       ----------------------------
                                    Name:  William P. Barnes
                                    Title: Senior Vice President/Treasurer

                                    BANK ONE, NA,
                                    a national banking association,
                                    as Collateral Agent

                                    By:
                                         ---------------------------
                                    Name:
                                         ---------------------------
                                    Title:
                                         ---------------------------

<PAGE>

         IN WITNESS WHEREOF, the Assignor and the Collateral Agent have duly
executed this Assignment under seal as of the day and year first above written.

                                    ARDENT HEALTH SERVICES, INC.
                                    a Delaware corporation

                                    By:
                                         ---------------------------
                                    Name:
                                         ---------------------------
                                    Title:
                                         ---------------------------

                                    BANK ONE, NA,
                                    a national banking association,
                                    as Collateral Agent

                                    By: /s/ Timothy K. Boyle
                                        ----------------------------
                                    Name:   Timothy K. Boyle
                                          --------------------------
                                    Title:  First Vice President
                                          --------------------------

<PAGE>

                                   EXHIBIT A

                                   DOCUMENTS

1. Amended and Restated Intercompany Promissory Note dated October 1, 2003
issued by Lovelace Health Systems, Inc., a New Mexico corporation in favor of
Ardent Health Services, Inc., in the amount of $70,000,000.

2. Security Agreement dated as of October 1, 2003 between Lovelace Health
Systems, Inc., a New Mexico corporation and Ardent Health Services, Inc.<PAGE>

                                                                     EXHIBIT 4.8

                                                                  EXECUTION COPY

                          REGISTRATION RIGHTS AGREEMENT

                                  BY AND AMONG

                          ARDENT HEALTH SERVICES, INC.

                                   AS ISSUER,

                                       AND
                           ARDENT HEALTH SERVICES LLC

                                       AND
              THE SUBSIDIARY GUARANTORS LISTED ON SCHEDULE A HERETO

                                  AS GUARANTORS

                         BANC OF AMERICA SECURITIES LLC

                               UBS SECURITIES LLC

                         BANE ONE CAPITAL MARKETS, INC.

               MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED

                           DATED AS OF AUGUST 19, 2003

<PAGE>

                          REGISTRATION RIGHTS AGREEMENT

                  This Registration Rights Agreement (the "Agreement") is made
and entered into as of August 19, 2003, by and among Ardent Health Services,
Inc., a Delaware corporation (the "Company"), Ardent Health Services LLC, a
Delaware limited liability company (the "Parent Guarantor") and the guarantors
listed on Schedule A hereto (the "Subsidiary Guarantors" and, together with the
Parent Guarantor, the "Guarantors"), and Banc of America Securities LLC, UBS
Securities LLC, Banc One Capital Markets, Inc. and Merrill Lynch, Pierce, Fenner
& Smith Incorporated (each an "Initial Purchaser" and, collectively, the
"Initial Purchasers"), each of whom has agreed to purchase the Company's 10%
Senior Subordinated Notes due 2013 (the "Initial Notes") pursuant to the
Purchase Agreement (as defined below).

                  This Agreement is made pursuant to the Purchase Agreement,
dated as of August 7, 2003 (the "Purchase Agreement"), by and among the Company,
the Guarantors and the Initial Purchasers (i) for the benefit of each Initial
Purchaser and (ii) for the benefit of the holders from time to time of the Notes
(including each Initial Purchaser). In order to induce the Initial Purchasers to
purchase the Initial Notes, the Company has agreed to provide the registration
rights set forth in this Agreement. The execution and delivery of this Agreement
is a condition to the obligations of the Initial Purchasers set forth in Section
5(h) of the Purchase Agreement.

                  The parties hereby agree as follows:

SECTION 1. DEFINITIONS

                  As used in this Agreement, the following capitalized terms
shall have the following meanings:

                  Broker-Dealer: Any broker or dealer registered with the
Commission under the Exchange Act.

                  Closing Date: The date of this Agreement.

                  Commission: The Securities and Exchange Commission.

                  Consummate: A registered Exchange Offer shall be deemed
         "Consummated" for purposes of this Agreement upon the occurrence of all
         of the following: (i) the filing and effectiveness under the Securities
         Act of the Exchange Offer Registration Statement relating to the
         Exchange Notes to be issued in the Exchange Offer, (ii) the maintenance
         of such Registration Statement continuously effective and the keeping
         of the Exchange Offer open for a period not less than the minimum
         period required pursuant to Section 3(b) hereof, and (iii) the delivery
         by the Company to the Registrar under the Indenture of Exchange Notes
         in the same aggregate principal amount as the aggregate principal
         amount of Initial Notes that were tendered by Holders thereof pursuant
         to the Exchange Offer.

                  Effectiveness Target Date: As defined in Section 5.

                  Exchange Act: The Securities Exchange Act of 1934, as amended.

                  Exchange Notes: The 10% Senior Subordinated Notes due 2013, of
         the same series under the Indenture as the Initial Notes, to be issued
         to Holders in exchange for Transfer Restricted Securities pursuant to
         this Agreement and the related guarantees (except that the Exchange
         Notes will not contain terms with respect to transfer restrictions and
         Liquidation Damages).

                  Exchange Offer: The registration by the Company under the
         Securities Act of the Exchange Notes pursuant to a Registration
         Statement pursuant to which the Company offers the Holders of all

<PAGE>

         outstanding Transfer Restricted Securities the opportunity to exchange
         all such outstanding Transfer Restricted Securities held by such
         Holders for Exchange Notes in an aggregate principal amount equal to
         the aggregate principal amount of the Transfer Restricted Securities
         tendered in such exchange offer by such Holders.

                  Exchange Offer Registration Statement: The Registration
         Statement relating to the Exchange Offer, including the related
         Prospectus.

                  Exempt Resales: The transactions in which the Initial
         Purchasers propose to sell the Initial Notes to certain "qualified
         institutional buyers," as such term is defined in Rule 144A under the
         Securities Act, and to non-U.S. persons pursuant to Regulation S under
         the Securities Act.

                  Holders: As defined in Section 2(b) hereof.

                  Indemnified Holder: As defined in Section 8(a) hereof.

                  Indenture: The Indenture, dated as of August 19, 2003, among
         the Company, the Guarantors and U.S. Bank Trust National Association,
         as trustee (the "Trustee"), pursuant to which the Notes are to be
         issued, as such Indenture is amended or supplemented from time to time
         in accordance with the terms thereof.

                  Initial Notes: The 10% Senior Subordinated Notes due 2013, of
         the same series under the Indenture as the Exchange Notes and the
         related guarantees, for so long as such securities constitute Transfer
         Restricted Securities.

                  Initial Placement: The issuance and sale by the Company of the
         Initial Notes to the Initial Purchasers pursuant to the Purchase
         Agreement.

                  Initial Purchaser: As defined in the preamble hereto.

                  Interest Payment Date: As defined in the Indenture and the
         Notes.

                  Liquidated Damages: As defined in Section 5 hereof.

                  NASD: National Association of Securities Dealers, Inc.

                  Notes: The Initial Notes and the Exchange Notes.

                  Person: An individual, partnership, corporation, trust or
         unincorporated organization, or a government or agency or political
         subdivision thereof.

                  Prospectus: The prospectus included in a Registration
         Statement, as amended or supplemented by any prospectus supplement and
         by all other amendments thereto, including post-effective amendments,
         and all material incorporated by reference into such Prospectus.

                  Record Holder: With respect to any Damages Payment Date
         relating to the Notes, each Person who is a Holder of Notes on the
         record date with respect to the Interest Payment Date on which such
         Damages Payment Date shall occur.

                  Registration Default: As defined in Section 5 hereof.

                  Registration Statement: Any registration statement of the
         Company relating to (a) an offering of Exchange Notes pursuant to an
         Exchange Offer or (b) the registration for resale of Transfer

                                       2
<PAGE>

         Restricted Securities pursuant to the Shelf Registration Statement,
         which is filed pursuant to the provisions of this Agreement, in each
         case, including the Prospectus included therein, all amendments and
         supplements thereto (including post-effective amendments) and all
         exhibits and material incorporated by reference therein.

                  Securities Act: The Securities Act of 1933, as amended.

                  Shelf Filing Deadline: As defined in Section 4 hereof.

                  Shelf Registration Statement: As defined in Section 4 hereof.

                  Transfer Restricted Securities: Each Initial Note, until the
         earliest to occur of (a) the date on which such Initial Note is
         exchanged in the Exchange Offer and entitled to be resold to the public
         by the Holder thereof without complying with the prospectus delivery
         requirements of the Securities Act, (b) the date on which such Initial
         Note has been effectively registered under the Securities Act and
         disposed of in accordance with a Shelf Registration Statement and (c)
         the date on which such Initial Note is distributed to the public
         pursuant to Rule 144 under the Securities Act or by a Broker-Dealer
         pursuant to the "Plan of Distribution" contemplated by the Exchange
         Offer Registration Statement (including delivery of the Prospectus
         contained therein).-

                  Trust Indenture Act: The Trust Indenture Act of 1939 (15
         U.S.C. Section 77aaa 77bbbb) as in effect on the date of the Indenture.

                  Underwritten Registration or Underwritten Offering: A
         registration in which securities of the Company are sold to an
         underwriter for reoffering to the public.

SECTION 2. SECURITIES SUBJECT TO THIS AGREEMENT

         (a)      Transfer Restricted Securities. The securities entitled to the
benefits of this Agreement are the Transfer Restricted Securities.

         (b)      Holders of Transfer Restricted Securities. A Person is deemed
to be a holder of Transfer Restricted Securities (each, a "Holder") whenever
such Person owns Transfer Restricted Securities.

SECTION 3. REGISTERED EXCHANGE OFFER

         (a)      Unless the Exchange Offer shall not be permissible under
applicable law or Commission policy (after the procedures set forth in Section
6(a) below have been complied with), the Company and the Guarantors shall (i)
cause to be filed with the Commission as soon as practicable after the Closing
Date, but in no event later than 120 days after the Closing Date, a Registration
Statement under the Securities Act relating to the Exchange Notes and the
Exchange Offer, (ii) use their reasonable best efforts to cause such
Registration Statement to become effective at the earliest possible time, but in
no event later than 210 days after the Closing Date, (iii) in connection with
the foregoing, (A) file all pre-effective amendments to such Registration
Statement as may be necessary in order to cause such Registration Statement to
become effective, (B) if applicable, file a post-effective amendment to such
Registration Statement pursuant to Rule 430A under the Securities Act and (C)
cause all necessary filings in connection with the registration and
qualification of the Exchange Notes to be made under the Blue Sky laws of such
jurisdictions as are necessary to permit Consummation of the Exchange Offer, and
(iv) upon the effectiveness of such Registration Statement, commence the
Exchange Offer. The Exchange Offer shall be on the appropriate form permitting
registration of the Exchange Notes to be offered in exchange for the Transfer
Restricted Securities and to permit resales of Notes held by Broker-Dealers as
contemplated by Section 3(c) below.

                                       3
<PAGE>

         (b)      The Company and the Guarantors shall use their reasonable best
efforts to cause the Exchange Offer Registration Statement to be effective
continuously and shall keep the Exchange Offer open for a period of not less
than the minimum period required under applicable federal and state securities
laws to Consummate the Exchange Offer; provided, however, that in no event shall
such period be less than 20 business days after the date notice of the Exchange
Offer is mailed to the Holders. The Company and the Guarantors shall cause the
Exchange Offer to comply with all applicable federal and state securities laws
in all material respects. No securities other than the Exchange Notes shall be
included in the Exchange Offer Registration Statement. The Company and the
Guarantors shall use their reasonable best efforts to cause the Exchange Offer
to be Consummated on the earliest practicable date after the Exchange Offer
Registration Statement has become effective, but in no event later than 30
business days after the date the Exchange Offer Registration Statement has
become effective.

         (c)      The Company shall indicate in a "Plan of Distribution" section
contained in the Prospectus forming a part of the Exchange Offer Registration
Statement that any Broker-Dealer who holds Initial Notes that are Transfer
Restricted Securities and that were acquired for its own account as a result of
market-making activities or other trading activities (other than Transfer
Restricted Securities acquired directly from the Company), may exchange such
Initial Notes pursuant to the Exchange Offer; provided, however, that such
Broker-Dealer may be deemed to be an "underwriter" within the meaning of the
Securities Act and must, therefore, deliver a prospectus meeting the
requirements of the Securities Act in connection with any resales of the
Exchange Notes received by such Broker-Dealer in the Exchange Offer, which
prospectus delivery requirement may be satisfied by the delivery by such
Broker-Dealer of the Prospectus contained in the Exchange Offer Registration
Statement. Such "Plan of Distribution" section shall also contain all other
information with respect to such resales by Broker-Dealers that the Commission
may require in order to permit such resales pursuant thereto, but such "Plan of
Distribution" shall not name any such Broker-Dealer or disclose the amount of
Notes held by any such Broker-Dealer except to the extent required by the
Commission as a result of a change in policy after the date of this Agreement.

                  The Company and the Guarantors shall use their reasonable best
efforts to keep the Exchange Offer Registration Statement continuously
effective, supplemented and amended as required by the provisions of Section
6(c) below to the extent necessary to ensure that it is available for resales of
Notes acquired by Broker-Dealers for their own accounts as a result of
market-making activities or other trading activities, and to ensure that it
conforms with the requirements of this Agreement, the Securities Act and the
policies, rules and regulations of the Commission as announced from time to
time, for a period ending on the earlier of (i) 180 days from the date on which
the Exchange Offer Registration Statement is declared effective and (ii) the
date on which a Broker-Dealer is no longer required to deliver a prospectus in
connection with market-making or other trading activities; provided, however,
that any such Broker-Dealer desiring the Company and the Guarantors to keep the
Exchange Offer Registration Statement continuously effective shall notify the
Company that such Broker-Dealer acquired Exchange Notes as a result of
market-making or other similar activities such that the Broker-Dealer would be
required to deliver a prospectus under the Securities Act upon a subsequent sale
or the other disposition of the Exchange Notes.

                  The Company shall provide sufficient copies of the latest
version of such Prospectus to Broker-Dealers promptly upon their reasonable
request at any time during such 180-day (or shorter as provided in the foregoing
sentence) period in order to facilitate such resales.

SECTION 4. SHELF REGISTRATION

         (a)      Shelf Registration. If (i) the Company and the Guarantors are
not required to file an Exchange Offer Registration Statement or to consummate
the Exchange Offer because the Exchange Offer is not permitted by applicable law
or Commission policy (after the procedures set forth in Section 6(a) below have
been complied with), (ii) for any reason the Exchange Offer is not Consummated
within 30 business days after the Effectiveness Target Date with respect to the
Exchange Offer Registration Statement, or (iii) with respect to any Holder of
Transfer Restricted Securities (A) such Holder is prohibited by applicable law
or

                                       4
<PAGE>

Commission policy from participating in the Exchange Offer, or (B) such Holder
may not resell the Exchange Notes acquired by it in the Exchange Offer to the
public without delivering a prospectus and that the Prospectus contained in the
Exchange Offer Registration Statement is not appropriate or available for such
resales by such Holder, or (C) such Holder is a Broker-Dealer and holds Initial
Notes acquired directly from the Company or one of its affiliates, then the
Company and the Guarantors shall (but, in the case of clause (iii) above, only
upon such Holder's request):

                  (x) cause to be filed a shelf registration statement pursuant
         to Rule 415 under the Securities Act, which may be an amendment to the
         Exchange Offer Registration Statement (in either event, the "Shelf
         Registration Statement") as soon as practicable but in any event on or
         prior to 45 days after the filing obligation arises (such date being
         the "Shelf Filing Deadline"), which Shelf Registration Statement shall
         provide for resales of all Transfer Restricted Securities the Holders
         of which shall have provided the information required pursuant to
         Section 4(b) hereof; and

                  (y) use their reasonable best efforts to cause such Shelf
         Registration Statement to be declared effective by the Commission on or
         before the 90th day after the Shelf Filing Deadline.

The Company and the Guarantors shall use their reasonable best efforts to keep
such Shelf Registration Statement continuously effective, supplemented and
amended as required by the provisions of Sections 6(b) and (c) hereof to the
extent necessary to ensure that it is available for resales of Notes by the
Holders of Transfer Restricted Securities entitled to the benefit of this
Section 4(a), and to ensure that it conforms with the requirements of this
Agreement, the Securities Act and the policies, rules and regulations of the
Commission as announced from time to time, for a period of at least two years
following the effective date of such Shelf Registration Statement (or shorter
period that will terminate when all the Notes covered by such Shelf Registration
Statement have been sold pursuant to such Shelf Registration Statement or are no
longer restricted securities (as defined in Rule 144 under the Securities Act)).

         (b)      Provision by Holders of Certain Information in Connection with
the Shelf Registration Statement. No Holder of Transfer Restricted Securities
may include any of its Transfer Restricted Securities in any Shelf Registration
Statement pursuant to this Agreement unless and until such Holder furnishes to
the Company in writing, within 20 business days after receipt of a request
therefor, such information as the Company may reasonably request for use in
connection with any Shelf Registration Statement or Prospectus or preliminary
Prospectus included therein. In the event that Liquidated Damages become due
solely as a result of a Holder of Transfer Restricted Securities having failed
to furnish the information specified in this Section 4(b), no such Holder shall
be entitled to such Liquidated Damages unless and until such Holder shall have
provided all such information. By acquiring the Initial Notes, each Holder
agrees to provide the indemnity set forth in Section 8(b) hereof with respect to
the information such Holder furnishes to the Company in writing expressly for
use in any Shelf Registration Statement. Each Holder as to which any Shelf
Registration Statement is being effected agrees to furnish promptly to the
Company all information required to be disclosed in order to make the
information previously furnished to the Company by such Holder not materially
misleading. The Company and the Guarantors shall not be obligated to supplement
such Shelf Registration Statement after it has been declared effective by the
Commission more than one time quarterly solely to reflect additional Holders.

SECTION 5. LIQUIDATED DAMAGES

                  If (i) any of the Registration Statements required by this
Agreement is not filed with the Commission on or prior to the date specified for
such filing in this Agreement, (ii) any of such Registration Statements has not
been declared effective by the Commission on or prior to the date specified for
such effectiveness in this Agreement (the "Effectiveness Target Date"), (iii)
the Exchange Offer has not been Consummated within 30 business days after the
Effectiveness Target Date with respect to the Exchange Offer Registration
Statement or (iv) any Registration Statement required by this Agreement is filed
and declared

                                       5
<PAGE>

effective but shall thereafter cease to be effective or fail to be usable for
its intended purpose without being succeeded within two business days by a
post-effective amendment to such Registration Statement that cures such failure
and that is itself promptly declared effective; provided, that, with respect to
a Shelf Registration Statement that the Company and the Guarantors are required
to keep effective pursuant to Section 4 hereof, the Company may suspend such
Shelf Registration Statement in excess of the period set forth in (iv) above so
long as such suspensions do not exceed 30 days in the aggregate in any
consecutive twelve-month period (each such event referred to in clauses (i)
through (iv), a "Registration Default"), the Company hereby agrees that the
interest rate borne by the Transfer Restricted Securities shall be increased by
0.50% per annum during the 90-day period immediately following the occurrence of
any Registration Default and shall increase by 0.50% per annum at the end of
each subsequent 90-day period, but in no event shall such increase exceed 1.5%
per annum (any such interest assessed upon the occurrence of a Registration
Default is referred to as "Liquidated Damages"). Following the cure of all
Registration Defaults relating to any particular Transfer Restricted Securities,
the interest rate borne by the relevant Transfer Restricted Securities will be
reduced to the original interest rate borne by such Transfer Restricted
Securities; provided, however, that, if after any such reduction in interest
rate, a different Registration Default occurs, the interest rate borne by the
relevant Transfer Restricted Securities shall again be increased pursuant to the
foregoing provisions.

                  Accrued Liquidated Damages shall be paid to Holders entitled
thereto, in the manner provided for the payment of interest in the Indenture and
the Notes, on each Interest Payment Date, as more fully set forth in the
Indenture and the Notes. All obligations of the Company and the Guarantors set
forth in the preceding paragraph that are outstanding with respect to any
Transfer Restricted Security at the time such security ceases to be a Transfer
Restricted Security shall survive until such time as all such obligations with
respect to such Note shall have been satisfied in full.

SECTION 6. REGISTRATION PROCEDURES

         (a)      Exchange Offer Registration Statement. In connection with the
Exchange Offer, the Company and the Guarantors shall comply with all of the
provisions of Section 6(c) below, shall use their reasonable best efforts to
effect such exchange to permit the sale of Transfer Restricted Securities being
sold in accordance with the intended method or methods of distribution thereof,
and shall comply with all of the following provisions:

                           (i)      If in the reasonable opinion of counsel to
the Company there is a question as to whether the Exchange Offer is permitted by
applicable law, the Company and the Guarantors hereby agree to seek a no-action
letter or other favorable decision from the Commission allowing the Company and
the Guarantors to Consummate an Exchange Offer for such Initial Notes. The
Company and the Guarantors each hereby agree to pursue the issuance of such a
decision to the Commission staff level but shall not be required to take
commercially unreasonable action to effect a change of Commission policy. The
Company and the Guarantors each hereby agree, however, to (A) participate in
telephonic conferences with the Commission, (B) deliver to the Commission staff
an analysis prepared by counsel to the Company setting forth the legal bases, if
any, upon which such counsel has concluded that such an Exchange Offer should be
permitted and (C) diligently pursue a favorable resolution by the Commission
staff of such submission.

                           (ii)     As a condition to its participation in the
Exchange Offer pursuant to the terms of this Agreement, each Holder of Transfer
Restricted Securities shall furnish, upon the request of the Company, prior to
the Consummation thereof, a written representation to the Company (which may be
contained in the letter of transmittal contemplated by the Exchange Offer
Registration Statement) to the effect that (A) it is not an affiliate of the
Company, (B) it is not engaged in, and does not intend to engage in, and has no
arrangement or understanding with any person to participate in, a distribution
of the Exchange Notes to be issued in the Exchange Offer and (C) it is acquiring
the Exchange Notes in its ordinary course of business. In addition, all such
Holders of Transfer Restricted Securities shall otherwise cooperate in the
Company's preparations for the Exchange Offer. Each Holder hereby acknowledges
and agrees that any Broker-Dealer and any such Holder using the Exchange Offer
to participate in a distribution of the securities to be acquired in the
Exchange Offer

                                       6
<PAGE>

(1) could not under Commission policy as in effect on the date of this Agreement
rely on the position of the Commission enunciated in Morgan Stanley and Co.,
Inc. (available June 5, 1991) and Exxon Capital Holdings Corporation (available
May 13, 1988), as interpreted in the Commission's letter to Shearman & Sterling
dated July 2, 1993, and similar no-action letters (which may include any
no-action letter obtained pursuant to clause (i) above), and (2) must comply
with the registration and prospectus delivery requirements of the Securities Act
in connection with a secondary resale transaction and that such a secondary
resale transaction should be covered by an effective registration statement
containing the selling security holder information required by Item 507 or 508,
as applicable, of Regulation S-K if the resales are of Exchange Notes obtained
by such Holder in exchange for Initial Notes acquired by such Holder directly
from the Company.

         (b)      Shelf Registration Statement. In connection with the Shelf
Registration Statement, the Company and the Guarantors shall comply with all the
provisions of Section 6(c) below and shall use their reasonable best efforts to
effect such registration to permit the sale of the Transfer Restricted
Securities being sold in accordance with the intended method or methods of
distribution thereof, and pursuant thereto the Company and the Guarantors will
as expeditiously as practicable prepare and file with the Commission a
Registration Statement relating to the registration on any appropriate form
under the Securities Act, which form shall be available for the sale of the
Transfer Restricted Securities in accordance with the intended method or methods
of distribution thereof.

         (c)      General Provisions. In connection with any Registration
Statement and any Prospectus required by this Agreement to permit the sale or
resale of Transfer Restricted Securities (including, without limitation, any
Registration Statement and the related Prospectus required to permit resales of
Notes by Broker-Dealers), the Company and the Guarantors shall:

                           (i)      use their reasonable best efforts to keep
such Registration Statement continuously effective and provide all requisite
financial statements (including, if required by the Securities Act or any
regulation thereunder, financial statements of the Guarantors for the period
specified in Section 3 or 4 of this Agreement, as applicable; upon the
occurrence of any event that would cause any such Registration Statement or the
Prospectus contained therein (A) to contain a material misstatement or omission
or (B) not to be effective and usable for resale of Transfer Restricted
Securities during the period required by this Agreement, the Company and the
Guarantors shall file promptly an appropriate amendment to such Registration
Statement, in the case of clause (A), correcting any such misstatement or
omission, and, in the case of either clause (A) or (B), use their reasonable
best efforts to cause such amendment to be declared effective and such
Registration Statement and the related Prospectus to become usable for their
intended purpose(s) as soon as practicable thereafter;

                           (ii)     prepare and file with the Commission such
amendments and post-effective amendments to the Registration Statement as may be
necessary to keep the Registration Statement effective for the applicable period
set forth in Section 3 or 4 hereof, as applicable, or such shorter period as
will terminate when all Transfer Restricted Securities covered by such
Registration Statement have been sold; cause the Prospectus to be supplemented
by any required Prospectus supplement, and as so supplemented to be filed
pursuant to Rule 424 under the Securities Act, and to comply fully with the
applicable provisions of Rules 424 and 430A under the Securities Act in a timely
manner; and comply with the provisions of the Securities Act with respect to the
disposition of all securities covered by such Registration Statement during the
applicable period in accordance with the intended method or methods of
distribution by the sellers thereof set forth in such Registration Statement or
supplement to the Prospectus;

                           (iii)    notify the underwriter(s), if any, and
selling Holders promptly and, if requested by such Persons, confirm such notice
in writing, (A) when the Prospectus or any Prospectus supplement or
post-effective amendment has been filed, and, with respect to any Registration
Statement or any post-effective amendment thereto, when the same has become
effective, (B) of any request by the Commission for amendments to the
Registration Statement or amendments or supplements to the Prospectus or for
additional information relating thereto, (C) of the issuance by the Commission
of any stop order suspending the

                                       7
<PAGE>

effectiveness of the Registration Statement under the Securities Act or of the
suspension by any state securities commission of the qualification of the
Transfer Restricted Securities for offering or sale in any jurisdiction, or the
initiation of any proceeding for any of the preceding purposes, (D) of the
existence of any fact or the happening of any event that makes any statement of
a material fact made in the Registration Statement, the Prospectus, any
amendment or supplement thereto, or any document incorporated by reference
therein, in light of the circumstances under which they were made, untrue, or
that requires the making of any additions to or changes in the Registration
Statement or the Prospectus in order to make the statements therein, in light of
the circumstances under which they were made, not misleading. If at any time the
Commission shall issue any stop order suspending the effectiveness of the
Registration Statement, or any state securities commission or other regulatory
authority shall issue an order suspending the qualification or exemption from
qualification of the Transfer Restricted Securities under state securities or
Blue Sky laws, the Company and the Guarantors shall use their reasonable best
efforts to obtain the withdrawal or lifting of such order at the earliest
possible time;

                           (iv)     if requested, furnish without charge to each
of the Initial Purchasers, each selling Holder named in any Registration
Statement, and each of the underwriter(s), if any, before filing with the
Commission, copies of any Registration Statement or any Prospectus included
therein or any amendments or supplements to any such Registration Statement or
Prospectus (including all documents incorporated by reference after the initial
filing of such Registration Statement), which documents will be subject to the
review of such Initial Purchasers, Holders and underwriter(s) in connection with
such sale, if any, for a period of at least five business days, and neither the
Company nor any Guarantor will file any such Registration Statement or
Prospectus or any amendment or supplement to any such Registration Statement or
Prospectus (including all such documents incorporated by reference) to which an
Initial Purchaser of Transfer Restricted Securities covered by such Registration
Statement or the undenvriter(s), if any, shall reasonably object in writing
within five business days after the receipt thereof (such objection to be deemed
timely made upon confirmation of telecopy transmission within such period). The
objection of an Initial Purchaser or underwriter, if any, shall be deemed to be
reasonable if such Registration Statement, amendment, Prospectus or supplement,
as applicable, as proposed to be filed, contains a material misstatement or
omission;

                           (v)      promptly prior to the filing of any document
that is to be incorporated by reference into a Registration Statement or
Prospectus, provide copies of such document to the Initial Purchasers, each
selling Holder named in any Registration Statement, and to the underwriter(s),
if any, make the Company's representatives and representatives of the Guarantors
available for discussion of such document and other customary due diligence
matters, and include such information in such document prior to the filing
thereof as such Initial Purchasers, selling Holders or underwriter(s), if any,
reasonably may request;

                           (vi)     make available at reasonable times for
inspection by the Initial Purchasers, any managing underwriter participating in
any disposition pursuant to such Registration Statement and any attorney or
accountant retained by such Initial Purchasers or any such managing
underwriter(s) (subject to such customary confidentiality arrangements as shall
be agreed to), all financial and other records, pertinent corporate documents
and properties of the Company and the Guarantors and cause the Company's and the
Guarantors' officers, directors and employees to supply all information
reasonably requested by any such Initial Purchaser, underwriter, attorney or
accountant in connection with such Registration Statement subsequent to the
filing thereof and prior to its effectiveness;

                           (vii)    if requested in writing by any selling
Holders or the underwriter(s), if any, promptly incorporate in any Registration
Statement or Prospectus, pursuant to a supplement or post-effective amendment if
necessary, such information as such selling Holders and underwriter(s), if any,
may reasonably request to have included therein, including, without limitation,
information relating to the "Plan of Distribution" of the Transfer Restricted
Securities, information with respect to the principal amount of Transfer
Restricted Securities being sold to such underwriter(s), the purchase price
being paid therefor and any other terms of the offering of the Transfer
Restricted Securities to be sold in such offering; and make all required

                                       8
<PAGE>

filings of such Prospectus supplement or post-effective amendment as soon as
practicable after the Company is notified of the matters to be incorporated in
such Prospectus supplement or post-effective amendment;

                           (viii)   use their reasonable best efforts to cause
the Transfer Restricted Securities covered by the Registration Statement to be
rated with the appropriate rating agencies, if so requested by the Holders of a
majority in aggregate principal amount of Notes covered thereby or the
underwriter(s), if any;

                           (ix)     furnish to each selling Holder and each of
the underwriter(s), if any, without charge, at least one copy of the
Registration Statement, as first filed with the Commission, and of each
amendment thereto, including financial statements and schedules, all documents
incorporated by reference therein and all exhibits (including exhibits
incorporated therein by reference);

                           (x)      deliver to each selling Holder and each of
the underwriter(s), if any, without charge, as many copies of the Prospectus
(including each preliminary prospectus) and any amendment or supplement thereto
as such Persons reasonably may request; the Company and the Guarantors hereby
consent to the use of the Prospectus and any amendment or supplement thereto by
each of the selling Holders and each of the underwriter(s), if any, in
connection with the offering and the sale of the Transfer Restricted Securities
covered by the Prospectus or any amendment or supplement thereto, subject to
compliance by each such Holder with the final paragraph of this Section 6;

                           (xi)     in the case of a Shelf Registration
Statement, upon request of Holders who collectively hold an aggregate principal
amount of Notes in excess of 20% of the outstanding principal amount of Transfer
Restricted Securities (the "Requesting Holders"), enter into, and cause the
Guarantors to enter into, such agreements (including an underwriting agreement),
and make, and cause the Guarantors to make, such representations and warranties,
and take all such other actions in connection therewith in order to expedite or
facilitate the disposition of the Transfer Restricted Securities pursuant to any
Shelf Registration Statement contemplated by this Agreement, all to such extent
as may be requested by any Initial Purchaser or by any Holder of Transfer
Restricted Securities or underwriter in connection with any sale or resale
pursuant to any Shelf Registration Statement contemplated by this Agreement; and
whether or not an underwriting agreement is entered into and whether or not the
registration is an Underwritten Registration, the Company and the Guarantors
shall:

                  (A)      upon the request of any Requesting Holders, furnish
         (or, in the case of paragraphs (2) and (3) below, use their reasonable
         best efforts to cause to be furnished) to each Initial Purchaser, each
         selling Holder and each underwriter, if any, in such substance and
         scope as they may request and as are customarily made by issuers to
         underwriters in primary underwritten offerings, upon the effectiveness
         of the Shelf Registration Statement:

                           (1)      a certificate, dated the date of
                  effectiveness of the Shelf Registration Statement signed by
                  (y) the President or any Vice President and (z) a principal
                  financial or accounting officer of each of the Company and the
                  Guarantors, confirming, as of the date thereof, the matters
                  set forth in paragraphs (i), (ii) and (iii) of Section 5 (e)
                  of the Purchase Agreement and such other matters as such
                  parties may reasonably request;

                           (2)      one or more opinions, dated the date of
                  effectiveness of the Shelf Registration Statement, of counsel
                  for the Company and the Guarantors, covering the matters set
                  forth in paragraph (c) of Section 5 of the Purchase Agreement
                  and such other matters as such parties may reasonably request,
                  and in any event including a statement to the effect that such
                  counsel has participated in conferences with officers and
                  other representatives of the Company and the Guarantors,
                  representatives of the independent public accountants for the
                  Company and the Guarantors, the Initial Purchasers'
                  representatives and the Initial Purchasers' counsel in
                  connection with the preparation of such Registration Statement
                  and the related Prospectus and have considered the matters
                  required to be stated therein and the

                                       9

<PAGE>

                  statements contained therein, although such counsel has not
                  independently verified the accuracy, completeness or fairness
                  of such statements; and that such counsel advises that, on the
                  basis of the foregoing (relying as to materiality to a large
                  extent upon facts provided to such counsel by officers and
                  other representatives of the Company and the Guarantors and
                  without independent check or verification), no facts came to
                  such counsel's attention that caused such counsel to believe
                  that the applicable Registration Statement, at the time such
                  Registration Statement or any post-effective amendment thereto
                  became effective, contained an untrue statement of a material
                  fact or omitted to state a material fact required to be stated
                  therein or necessary to make the statements therein not
                  misleading, or that the Prospectus contained in such
                  Registration Statement as of its date contained an untrue
                  statement of a material fact or omitted to state a material
                  fact necessary in order to make the statements therein, in
                  light of the circumstances under which they were made, not
                  misleading. Without limiting the foregoing, such counsel may
                  state further that such counsel assumes no responsibility for,
                  and has not independently verified, the accuracy, completeness
                  or fairness of the financial statements, notes and schedules
                  and other financial data included in any Shelf Registration
                  Statement contemplated by this Agreement or the related
                  Prospectus; and

                           (3) a customary comfort letter, dated as of the date
                  of effectiveness of the Shelf Registration Statement, from the
                  Company's or the Parent Guarantor's independent accountants,
                  in the customary form and covering matters of the type
                  customarily covered in comfort letters by underwriters in
                  connection with primary underwritten offerings, and affirming
                  the matters set forth in the comfort letters delivered
                  pursuant to Section 5(a) of the Purchase Agreement and;

                  (B) deliver such other documents and certificates as may be
         reasonably requested by such parties to evidence compliance with clause
         (A) above and with any customary conditions contained in the
         underwriting agreement or other agreement entered into by the Company
         or the Guarantors pursuant to this clause (xi), if any.

                  If at any time the representations and warranties of the
Company and the Guarantors contemplated in clause (A)(1) above cease to be true
and correct, the Company or the Guarantors, as the case may be, shall so advise
the Initial Purchasers and the underwriter(s), if any, and each selling Holder
promptly and, if requested by such Persons, shall confirm such advice in
writing;

                           (xii)    prior to any public offering of Transfer
Restricted Securities, cooperate with, and cause the Guarantors to cooperate
with, the selling Holders, the underwriter(s), if any, and their respective
counsel in connection with the registration and qualification of the Transfer
Restricted Securities under the securities or Blue Sky laws of such
jurisdictions as the selling Holders or underwriter(s) may reasonably request
and do any and all other acts or things necessary or advisable to enable the
disposition in such jurisdictions of the Transfer Restricted Securities covered
by the Shelf Registration Statement; provided, however, that neither the Company
nor any Guarantor shall be required to register or qualify as a foreign
corporation where it is not then so qualified or to take any action that would
subject it to the service of process in suits or to taxation, other than as to
matters and transactions relating to the Registration Statement, in any
jurisdiction where it is not then so subject;

                           (xiii)   shall issue, upon the request of any Holder
of Initial Notes covered by the Shelf Registration Statement, Exchange Notes,
having an aggregate principal amount equal to the aggregate principal amount of
Initial Notes surrendered to the Company by such Holder in exchange therefor or
being sold by such Holder; such Exchange Notes to be registered in the name of
such Holder or in the name of the purchaser(s) of such Notes, as the case may
be; in return, the Initial Notes held by such Holder shall be surrendered to the
Company for cancellation;

                                       10

<PAGE>

                           (xiv)    cooperate with, and cause the Guarantors to
cooperate with, the selling Holders and the underwriter(s), if any, to
facilitate the timely preparation and delivery of certificates representing
Transfer Restricted Securities to be sold and not bearing any restrictive
legends; and enable such Transfer Restricted Securities to be in such
denominations and registered in such names as the Holders or the underwriter(s),
if any, may request at least two business days prior to any sale of Transfer
Restricted Securities made by such underwriter(s);

                           (xv)     use their reasonable best efforts to cause
the Transfer Restricted Securities covered by the Registration Statement to be
registered with or approved by such other governmental agencies or authorities
as may be necessary to enable the seller or sellers thereof or the
underwriter(s), if any, to consummate the disposition of such Transfer
Restricted Securities, subject to the proviso contained in clause (viii) above;

                           (xvi)    if any fact or event contemplated by clause
(c)(iii)(D) above shall exist or have occurred, prepare a supplement or
post-effective amendment to the Registration Statement or related Prospectus or
any document incorporated therein by reference or file any other required
document so that, as thereafter delivered to the purchasers of Transfer
Restricted Securities, the Prospectus will not contain an untrue statement of a
material fact or omit to state any material fact necessary to make the
statements therein, in light of the circumstances under which they were made,
not misleading;

                           (xvii)   provide a CUSIP number for all Transfer
Restricted Securities not later than the effective date of the Registration
Statement and provide the Trustee under the Indenture with printed certificates
for the Transfer Restricted Securities which are in a form eligible for deposit
with the Depositary Trust Company;

                           (xviii)  cooperate and assist in any filings required
to be made with the NASD and in the performance of any due diligence
investigation by any underwriter (including any "qualified independent
underwriter") that is required to be retained in accordance with the rules and
regulations of the NASD, and use their reasonable best efforts to cause such
Registration Statement to become effective and approved by such U.S. federal,
state or local governmental agencies or authorities as may be necessary to
enable the Holders selling Transfer Restricted Securities to consummate the
disposition of such Transfer Restricted Securities;

                           (xix)    otherwise use their reasonable best efforts
to comply with all applicable rules and regulations of the Commission, and make
generally available to its security holders, as soon as practicable, a
consolidated earnings statement meeting the requirements of Rule 158 (which need
not be audited) for the twelve-month period (A) commencing at the end of any
fiscal quarter in which Transfer Restricted Securities are sold to underwriters
in a firm or best efforts Underwritten Offering or (B) if not sold to
underwriters in such an offering, beginning with the first month of the
Company's first fiscal quarter commencing after the effective date of the
Registration Statement;

                           (xx)     cause the Indenture to be qualified under
the Trust Indenture Act not later than the effective date of the first
Registration Statement required by this Agreement, and, in connection therewith,
cooperate with, and cause the Guarantors to cooperate with, the Trustee and the
Holders of Notes to effect such changes to the Indenture as may be required for
such Indenture to be so qualified in accordance with the terms of the Trust
Indenture Act; and to execute, and cause the Guarantors to execute, and use
their reasonable best efforts to cause the Trustee to execute, all documents
that may be required to effect such changes and all other forms and documents
required to be filed with the Commission to enable such Indenture to be so
qualified in a timely manner;

                           (xxi)    cause all Transfer Restricted Securities
covered by the Registration Statement to be listed on each securities exchange
on which similar securities issued by the Company are then listed if requested
by the Holders of a majority in aggregate principal amount of Initial Notes or
any underwriter(s), if any; and

                                       11
<PAGE>

                  (xxii)   provide promptly to each Holder upon request each
document filed with the Commission pursuant to the requirements of Section 13
and Section 15 of the Exchange Act to the extent any such document is not
available through the Commission's EDGAR system.

                  Each Holder agrees by acquisition of a Transfer Restricted
Security that, upon receipt of any notice from the Company in accordance with
Section 6(c)(iii) of any event described in clauses (C) or (D) of Section
6(c)(iii) hereof, such Holder will forthwith discontinue disposition of Transfer
Restricted Securities pursuant to the applicable Registration Statement until
such Holder's receipt of the copies of the supplemented or amended Prospectus
contemplated by Section 6(c)(xvi) hereof, or until it is advised in writing (the
"Advice") by the Company that the use of the Prospectus may be resumed, and has
received copies of any additional or supplemental filings that are incorporated
by reference in the Prospectus. If so directed by the Company, each Holder will
deliver to the Company (at the Company's expense) all copies, other than
permanent file copies then in such Holder's possession, of the Prospectus
covering such Transfer Restricted Securities that was current at the time of
receipt of such notice. In the event the Company shall give any such notice, the
time period regarding the effectiveness of such Registration Statement set forth
in Section 3 or 4 hereof, as applicable, shall be extended by the number of days
during the period from and including the date of the giving of such notice in
accordance with Section 6(c)(iii) of any event described in clauses (C) or (D)
of Section 6(c)(iii) hereof to and including the date when each selling Holder
covered by such Registration Statement shall have received the copies of the
supplemented or amended Prospectus contemplated by Section 6(c)(xvi) hereof or
shall have received the Advice; however, no such extension shall be taken into
account in determining whether Liquidated Damages are due pursuant to Section 5
hereof or the amount of such Liquidated Damages, it being agreed that the
Company's option to suspend use of a Registration Statement (in the case of
suspension of a Shelf Registration Statement, for more than 30 days in the
aggregate in any consecutive twelve-month period) pursuant to this paragraph
shall be treated as a Registration Default for purposes of Section 5.

SECTION 7. REGISTRATION EXPENSES

         (a)      All expenses incident to the Company's or the Guarantors'
performance of or compliance with this Agreement will be borne by the Company or
the Guarantors, regardless of whether a Registration Statement becomes
effective, including without limitation: (i) all registration and filing fees
and expenses (including filings made by any Initial Purchaser or Holder with the
NASD (and, if applicable, the fees and expenses of any "qualified independent
underwriter" and its counsel that may be required by the rules and regulations
of the NASD)); (ii) all fees and expenses of compliance with federal securities
and state Blue Sky or securities laws; (iii) all expenses of printing (including
printing certificates for the Exchange Notes to be issued in the Exchange Offer
and printing of Prospectuses), messenger and delivery services and telephone;
(iv) all fees and disbursements of counsel for the Company, the Guarantors and,
subject to Section 7(b) below, the Holders of Transfer Restricted Securities;
(v) all application and filing fees in connection with listing the Exchange
Notes on a national securities exchange or automated quotation system pursuant
to the requirements thereof; and (vi) all fees and disbursements of independent
certified public accountants of the Company and the Guarantors (including the
expenses of any special audit and comfort letters required by or incident to
such performance).

                  The Company and the Guarantors will, in any event, bear their
internal expenses (including, without limitation, all salaries and expenses of
its officers and employees performing legal or accounting duties), the expenses
of any annual audit and the fees and expenses of any Person, including special
experts, retained by the Company and the Guarantors.

         (b)      In connection with any Shelf Registration Statement required
by this Agreement, the Company and the Guarantors will reimburse the Initial
Purchasers and the Holders of Transfer Restricted Securities being registered
pursuant to the Shelf Registration Statement for the reasonable fees and
disbursements of not more than one counsel, who shall be Shearman & Sterling LLP
or such other counsel as

                                       12

<PAGE>

may be chosen by the Holders of a majority in principal amount of the Transfer
Restricted Securities for whose benefit such Shelf Registration Statement is
being prepared.

SECTION 8. INDEMNIFICATION

         (a)      The Company agrees and the Guarantors, jointly and severally,
agree to indemnify and hold harmless (i) each Holder, (ii) each Person, if any,
who controls (within the meaning of Section 15 of the Securities Act or Section
20 of the Exchange Act) any Holder (any of the persons referred to in this
clause (ii) being hereinafter referred to as a "controlling person") and (iii)
the respective officers, directors, partners, employees, representatives and
agents of any Holder or any controlling person (any person referred to in clause
(i), (ii) or (iii) may hereinafter be referred to as an "Indemnified Holder"),
to the fullest extent lawful, from and against any and all losses, claims,
damages, liabilities, judgments, actions and expenses (including without
limitation and as incurred, reimbursement of all reasonable costs of
investigating, preparing, pursuing, settling, compromising, paying or defending
any claim or action, or any investigation or proceeding by any governmental
agency or body, commenced or threatened, including the reasonable fees and
expenses of counsel to any Indemnified Holder), joint or several, directly or
indirectly caused by, related to, based upon, arising out of or in connection
with any untrue statement or alleged untrue statement of a material fact
contained in any Registration Statement or Prospectus (or any amendment or
supplement thereto), or any omission or alleged omission to state therein a
material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they were made, not
misleading, except insofar as such losses, claims, damages, liabilities or
expenses are caused by an untrue statement or omission or alleged untrue
statement or omission (x) that is made in reliance upon and in conformity with
information relating to any of the Holders furnished in writing to the Company
by any of the Holders expressly for use therein or was made in a Prospectus as
to which such Indemnified Holder (in its capacity as Holder) or underwriter (or
any person who controls such party within the meaning of Section 15 of the
Securities Act or Section 20 of the Exchange Act) had previously received a
notice from the Company in accordance with Section 6(c)(iii) of any event
described in clauses (C) or (D) of Section 6(c)(iii) hereof and such notice had
not been followed by an Advice or a supplemented or amended Prospectus. This
indemnity agreement shall be in addition to any liability which the Company or
the Guarantors may otherwise have.

                  In case any action or proceeding (including any governmental
or regulatory investigation or proceeding) shall be brought or asserted against
any of the Indemnified Holders with respect to which indemnity may be sought
against the Company or the Guarantors, such Indemnified Holder (or the
Indemnified Holder controlled by such controlling person) shall promptly notify
the Company and the Guarantors in writing (provided, that the failure to give
such notice shall not relieve the Company or the Guarantors from any liability
which they may have to any Indemnified Holder for contribution or under the
indemnity agreement contained in this Section 8 except to the extent it is
prejudiced as a proximate result of such failure. Such Indemnified Holder shall
have the right to employ its own counsel in any such action and the reasonable
fees and expenses of such counsel shall be paid, as incurred, by the Company and
the Guarantors (regardless of whether it is ultimately determined that an
Indemnified Holder is not entitled to indemnification hereunder). The Company
and the Guarantors shall not, in connection with any one such action or
proceeding or separate but substantially similar or related actions or
proceedings in the same jurisdiction arising out of the same general allegations
or circumstances, be liable for the reasonable fees and expenses of more than
one separate firm of attorneys (in addition to any local counsel) at any time
for such Indemnified Holders, which firm shall be designated by the Holders. The
Company and the Guarantors shall be liable for any settlement of any such action
or proceeding effected with the Company's prior written consent, which consent
shall not be withheld unreasonably, and the Company and the Guarantors agree to
indemnify and hold harmless any Indemnified Holder from and against any loss,
claim, damage, liability or expense by reason of any settlement of any such
action effected with the written consent of the Company. The Company and the
Guarantors shall not, without the prior written consent of each Indemnified
Holder, settle or compromise or consent to the entry of judgment in or otherwise
seek to terminate any pending or threatened action, claim, litigation or
proceeding in respect of which indemnification or contribution may be sought
hereunder (whether or not any Indemnified Holder is a party thereto), unless
such settlement, compromise,

                                       13

<PAGE>

consent or termination includes an unconditional release of each Indemnified
Holder from all liability arising out of such action, claim, litigation or
proceeding.

         (b)      Each Holder of Transfer Restricted Securities agrees,
severally and not jointly, to indemnify and hold harmless the Company and the
Guarantors and their respective directors and officers who sign a Registration
Statement, and any person controlling (within the meaning of Section 15 of the
Securities Act or Section 20 of the Exchange Act) the Company, the Guarantors
and the respective officers, directors, partners, employees, representatives and
agents of each such person, to the same extent as the foregoing indemnity from
the Company and the Guarantors to each of the Indemnified Holders, but only with
respect to claims and actions based on information relating to such Holder
furnished in writing by such Holder expressly for use in any Registration
Statement. In case any action or proceeding shall be brought against the
Company, the Guarantors or their directors or officers or any such controlling
person in respect of which indemnity may be sought against a Holder of Transfer
Restricted Securities, such Holder shall have the rights and duties given the
Company and/or the Guarantors and the Company, the Guarantors or their directors
or officers or such controlling person shall have the rights and duties given to
each Holder by the preceding paragraph. In no event shall the liability of any
selling Holder hereunder be greater in amount than the dollar amount of the
proceeds received by such Holder upon the sale of the Securities giving rise to
such indemnification obligation.

         (c)      If the indemnification provided for in this Section 8 is
unavailable to an indemnified party under Section 8(a) or Section 8(b) hereof
(other than by reason of exceptions provided in those Sections) in respect of
any losses, claims, damages, liabilities, judgments, actions or expenses
referred to therein, then each applicable indemnifying party, in lieu of
indemnifying such indemnified party, shall contribute to the amount paid or
payable by such indemnified party as a result of such losses, claims, damages,
liabilities or expenses in such proportion as is appropriate to reflect the
relative benefits received by the Company and the Guarantors, on the one hand,
and the Holders, on the other hand, from the Initial Placement (which in the
case of the Company shall be deemed to be equal to the total gross proceeds from
the Initial Placement as set forth on the cover page of the Offering
Memorandum), the amount of Liquidated Damages which did not become payable as a
result of the filing of the Registration Statement resulting in such losses,
claims, damages, liabilities, judgments actions or expenses, and such
Registration Statement, or if such allocation is not permitted by applicable
law, the relative fault of the Company and the Guarantors on the one hand, and
of the Indemnified Holder, on the other hand, in connection with the statements
or omissions which resulted in such losses, claims, damages, liabilities or
expenses, as well as any other relevant equitable considerations. The relative
fault of the Company on the one hand and of the Indemnified Holder on the other
shall be determined by reference to, among other things, whether the untrue or
alleged untrue statement of a material fact or the omission or alleged omission
to state a material fact relates to information supplied by the Company or by
the Indemnified Holder and the parties' relative intent, knowledge, access to
information and opportunity to correct or prevent such statement or omission.
The amount paid or payable by a party as a result of the losses, claims,
damages, liabilities and expenses referred to above shall be deemed to include,
subject to the limitations set forth in the second paragraph of Section 8(a),
any legal or other fees or expenses reasonably incurred by such party in
connection with investigating or defending any action or claim.

                  The Company, the Guarantors and each Holder of Transfer
Restricted Securities agree that it would not be just and equitable if
contribution pursuant to this Section 8(c) were determined by pro rata
allocation (even if the Holders were treated as one entity for such purpose) or
by any other method of allocation which does not take account of the equitable
considerations referred to in the immediately preceding paragraph. The amount
paid or payable by an indemnified party as a result of the losses, claims,
damages, liabilities or expenses referred to in the immediately preceding
paragraph shall be deemed to include, subject to the limitations set forth
above, any legal or other expenses reasonably incurred by such indemnified party
in connection with investigating or defending any such action or claim.
Notwithstanding the provisions of this Section 8, none of the Holders (and its
related Indemnified Holders) shall be required to contribute, in the aggregate,
any amount in excess of the amount by which the net proceeds received by such
Holder upon the sale of the Initial Notes exceeds the amount of any damages
which such Holder has otherwise been required to pay by reason of such untrue or
alleged untrue statement or omission or alleged omission. No person guilty of

                                       14
<PAGE>

fraudulent misrepresentation (within the meaning of Section ll(f) of the
Securities Act) shall be entitled to contribution from any person who was not
guilty of such fraudulent misrepresentation. The Holders' obligations to
contribute pursuant to this Section 8(c) are several in proportion to the
respective principal amount of Transfer Restricted Securities held by each of
the Holders hereunder and not joint.

SECTION 9. RULE 144A

                  The Company and the Guarantors each hereby agrees with each
Holder, for so long as any Transfer Restricted Securities remain outstanding, to
make available to any Holder or beneficial owner of Transfer Restricted
Securities in connection with any sale thereof and any prospective purchaser of
such Transfer Restricted Securities from such Holder or beneficial owner, the
information required by Rule 144A(d)(4) under the Securities Act in order to
permit resales of such Transfer Restricted Securities pursuant to Rule 144A.

SECTION 10. PARTICIPATION IN UNDERWRITTEN REGISTRATIONS

                  No Holder may participate in any Underwritten Registration
hereunder unless such Holder (a) agrees to sell such Holder's Transfer
Restricted Securities on the basis provided in any underwriting arrangements
approved by the Persons entitled hereunder to approve such arrangements and (b)
completes and executes all reasonable questionnaires, powers of attorney,
indemnities, underwriting agreements, lock-up letters and other documents
required under the terms of such underwriting arrangements.

SECTION 11. SELECTION OF UNDERWRITERS

                  The Holders of Transfer Restricted Securities covered by the
Shelf Registration Statement who desire to do so may sell such Transfer
Restricted Securities in an Underwritten Offering. In any such Underwritten
Offering, the investment banker or investment bankers and manager or managers
that will administer the offering will be selected by the Holders of a majority
in aggregate principal amount of the Transfer Restricted Securities included in
such offering; provided that such investment bankers and managers must be
reasonably satisfactory to the Company and provided, further, that such Holders
shall be responsible for all underwriting commissions and discounts in
connection therewith.

SECTION 12. MISCELLANEOUS

         (a)      Remedies. The Company and the Guarantors each hereby agrees
that monetary damages would not be adequate compensation for any loss incurred
by reason of a breach by it of the provisions of this Agreement and hereby agree
to waive the defense in any action for specific performance that a remedy at law
would be adequate; provided that the Liquidated Damages contemplated in Section
5 hereof shall be the exclusive remedy for any breach of Section 3 and 4 hereof.

         (b)      No Inconsistent Agreements. The Company will not, and will
cause the Guarantors not to, on or after the date of this Agreement enter into
any agreement with respect to its securities that is inconsistent with the
rights granted to the Holders in this Agreement or otherwise conflicts with the
provisions hereof. Other than pursuant to this Agreement, neither the Company
nor any Guarantor has entered into any agreement granting any registration
rights with respect to its securities to any Person. The rights granted to the
Holders hereunder do not in any way conflict with and are not inconsistent with
the rights granted to the holders of the Company's securities under any
agreement in effect on the date hereof.

         (c)      Adjustments Affecting the Notes. Neither the Company nor any
Guarantor will take any action, or permit any change to occur, with respect to
the Notes that would materially and adversely affect the ability of the Holders
to Consummate any Exchange Offer.

                                       15
<PAGE>

         (d)      Amendments and Waivers. The provisions of this Agreement may
not be amended, modified or supplemented, and waivers or consents to or
departures from the provisions hereof may not be given unless the Company has
obtained the written consent of Holders of a majority of the outstanding
principal amount of Transfer Restricted Securities. Notwithstanding the
foregoing, a waiver or consent to departure from the provisions hereof that
relates exclusively to the rights of Holders whose securities are being tendered
pursuant to the Exchange Offer and that does not affect directly or indirectly
the rights of other Holders whose securities are not being tendered pursuant to
such Exchange Offer may be given by the Holders of a majority of the outstanding
principal amount of Transfer Restricted Securities being tendered or registered;
provided that, with respect to any matter that directly or indirectly affects
the rights of any Initial Purchaser hereunder, the Company shall obtain the
written consent of each such Initial Purchaser with respect to which such
amendment, qualification, supplement, waiver, consent or departure is to be
effective.

         (e)      Notices. All notices and other communications provided for or
permitted hereunder shall be made in writing by hand-delivery, first-class mail
(registered or certified, return receipt requested), telex, telecopier, or air
courier guaranteeing overnight delivery:

                  (i)      if to a Holder, at the address set forth on the
records of the Registrar under the Indenture, with a copy to the Registrar under
the Indenture; and

                  (ii)     if to the Initial Purchasers:

                                    Banc of America Securities LLC
                                    9 West 57th Street, 6th Floor
                                    New York, NY 10019

                                    Facsimile: (212) 847-6441
                                    Attention: High Yield Capital Markets

                                    with a copy to:

                                    Shearman & Sterling
                                    599 Lexington Avenue
                                    New York, NY 1002

                                    Facsimile: (212) 848-7179
                                    Attention: Rohan S. Weerasinghe

                  (iii)    if to the Company:

                                    Ardent Health Services, Inc.
                                    One Burton Hills Boulevard
                                    Suite 250
                                    Nashville, TN 37215
                                    Facsimile: (615) 296-6384
                                    Attention: General Counsel

              With a copy to:

                                    Boult, Cummings, Conners & Berry PLC
                                    Suite 1600
                                    414 Union Street
                                    Nashville, TN 37219

                                       16
<PAGE>

                                    Facsimile: (615) 252-6300
                                    Attention: Stephen T. Braun

                      (iv)     if to the Guarantors:

                                    c/o Ardent Health Services LLC
                                    One Burton Hills Boulevard
                                    Suite 250
                                    Nashville, TN 37215
                                    Facsimile: (615) 296-6384
                                    Attention: General Counsel

                  With a copy to:

                                    Boult, Cummings, Conners & Berry PLC
                                    Suite 1600
                                    414 Union Street
                                    Nashville, TN 37219
                                    Facsimile: (615) 252-6300
                                    Attention: Stephen T. Braun

                  All such notices and communications shall be deemed to have
been duly given: at the time delivered by hand, if personally delivered; five
business days after being deposited in the mail, postage prepaid, if mailed;
when answered back, if telexed; when receipt acknowledged, if telecopied; and on
the next business day, if timely delivered to an air courier guaranteeing
overnight delivery.

                  Copies of all such notices, demands or other communications
shall be concurrently delivered by the Person giving the same to the Trustee at
the address specified in the Indenture.

         (f)      Successors and Assigns. This Agreement shall inure to the
benefit of and be binding upon the successors and assigns of each of the
parties, including without limitation and without the need for an express
assignment, subsequent Holders of Transfer Restricted Securities; provided,
however, that this Agreement shall not inure to the benefit of or be binding
upon a successor or assign of a Holder unless and to the extent such successor
or assign acquired Transfer Restricted Securities from such Holder.

         (g)      Counterparts. This Agreement may be executed in any number of
counterparts and by the parties hereto in separate counterparts, each of which
when so executed shall be deemed to be an original and all of which taken
together shall constitute one and the same agreement.

         (h)      Headings. The headings in this Agreement are for convenience
of reference only and shall not limit or otherwise affect the meaning hereof.

         (i)      GOVERNING LAW. THIS AGREEMENT SHALL BE GOVERNED BY AND
CONSTRUED IN ACCORDANCE WITH THE INTERNAL LAWS OF THE STATE OF NEW YORK
APPLICABLE TO AGREEMENTS MADE AND TO BE PERFORMED IN SUCH STATE.

         (j)      Severability. In the event that any one or more of the
provisions contained herein, or the application thereof in any circumstance, is
held invalid, illegal or unenforceable, the validity, legality and
enforceability of any such provision in every other respect and of the remaining
provisions contained herein shall not be affected or impaired thereby.

         (k)      Entire Agreement. This Agreement is intended by the parties as
a final expression of their agreement and intended to be a complete and
exclusive statement of the agreement and understanding of the

                                       17
<PAGE>

parties hereto in respect of the subject matter contained herein. There are no
restrictions, promises, warranties or undertakings, other than those set forth
or referred to herein with respect to the registration rights granted by the
Company with respect to the Transfer Restricted Securities. This Agreement
supersedes all prior agreements and understandings between the parties with
respect to such subject matter.

                                       18
<PAGE>

                  IN WITNESS WHEREOF, the parties have executed this
Registration Rights Agreement as of the date first written above.

                                    ARDENT HEALTH SERVICES, INC.

                                    By: /s/ W. Page Barnes
                                        ----------------------------------------
                                        Name: W. Page Barnes
                                        Title: Senior Vice President and
                                               Chief Financial Officer

                                    ARDENT HEALTH SERVICES LLC

                                    By: /s/ W. Page Barnes
                                        ----------------------------------------
                                        Name: W. Page Barnes
                                        Title: Senior Vice President and
                                               Chief Financial Officer

<PAGE>

                                          AHS ALBURQUERQUE HOLDINGS, LLC
                                          AHS ALBUQUERQUE REGIONAL MEDICAL
                                          CENTER, LLC
                                          AHS ALBUQUERQUE PHYSICIAN GROUP,
                                          LLC
                                          AHS ALBUQUERQUE REHABILITATION
                                          HOSPITAL, LLC
                                          AHS CUMBERLAND HOSPITAL, LLC
                                          AHS KENTUCKY HOLDINGS, INC.
                                          AHS KENTUCKY HOSPITALS, INC.
                                          AHS LOUISIANA HOLDINGS, INC.
                                          AHS LOUISIANA HOSPITALS, INC.
                                          AHS MANAGEMENT COMPANY, INC.
                                          AHS MANAGEMENT SERVICES OF NEW
                                          JERSEY, LLC
                                          AHS NEW MEXICO HOLDINGS, INC.
                                          AHS NORTHEAST HEIGHTS HOSPITAL, LLC
                                          AHS RESEARCH AND REVIEW, LLC
                                          AHS SAMARITAN HOSPITAL, LLC
                                          AHS S.E.D. MEDICAL LABORATORIES, INC.
                                          AHS SUMMIT HOSPITAL, LLC
                                          AHS WEST MESA HOSPITAL, LLC
                                          ARDENT MEDICAL SERVICES, INC.
                                          BEHAVIORAL HEALTHCARE CORPORATION
                                          BHC ALHAMBRA HOSPITAL, INC.
                                          BHC BELMONT PINES HOSPITAL, INC.
                                          BHC CEDAR CREST RTC, INC.
                                          BHC CEDAR VISTA HOSPITAL, INC.
                                          BHC CLINICAS DEL ESTE HOSPITAL, INC.
                                          BHC COLUMBUS HOSPITAL, INC.
                                          BHC FAIRFAX HOSPITAL, INC.
                                          BHC FORT LAUDERDALE HOSPITAL, INC.
                                          BHC FOX RUN HOSPITAL, INC.
                                          BHC FREEMONT HOSPITAL, INC.
                                          BHC GULF COAST MANAGEMENT GROUP,
                                          INC.
                                          BHC HEALTH SERVICES OF NEVADA, INC.
                                          BHC HERITAGE OAKS HOSPITAL, INC.
                                          BHC HOSPITAL HOLDINGS, INC.
                                          BHC INTERMOUNTAIN HOSPITAL, INC.
                                          BHC LEBANON HOSPITAL, INC.
                                          BHC MANAGEMENT HOLDINGS, INC.

<PAGE>

                                          BHC MANAGEMENT SERVICES, LLC
                                          BHC MANAGEMENT SERVICES OF INDIANA,
                                          LLC
                                          BHC MANAGEMENT SERVICES OF
                                          KENTUCKY, LLC
                                          BHC MANAGEMENT SERVICES OF NEW
                                          MEXICO, LLC
                                          BHC MANAGEMENT SERVICES OF
                                          PENNSYLVANIA, LLC
                                          BHC MANAGEMENT SERVICES OF
                                          STREAMWOOD, LLC
                                          BHC MEADOWS PARTNER, INC.
                                          BHC MILLWOOD HOSPITAL, INC.
                                          BHC MONTEVISTA HOSPITAL, INC.
                                          BHC NORTHWEST PSYCHIATRIC HOSPITAL,
                                          LLC
                                          BHC OF INDIANA, GENERAL PARTNERSHIP
                                          BHC OF NORTHERN INDIANA, INC.
                                          BHC PACIFIC GATEWAY HOSPITAL, INC.
                                          BHC PACIFIC SHORES HOSPITAL, INC.
                                          BHC PACIFIC VIEW RTC, INC.
                                          BHC PHYSICIAN SERVICES OF KENTUCKY,
                                          LLC
                                          BHC PINNACLE POINTE HOSPITAL, INC.
                                          BHC PROPERTIES, INC.
                                          BHC ROSS HOSPITAL, INC.
                                          BHC SAN JUAN CAPESTRANO HOSPITAL,
                                          INC.
                                          BHC SIERRA VISTA HOSPITAL, INC.
                                          BHC SPIRIT OF ST. LOUIS HOSPITAL, INC.
                                          BHC STREAMWOOD HOSPITAL, INC.
                                          BHC VALLE VISTA HOSPITAL, INC.
                                          BHC VISTA DEL MAR HOSPITAL, INC.
                                          BHC WINDSOR HOSPITAL, INC.
                                          BLOOMINGTON MEADOWS, G.P.
                                          COLUMBUS HOSPITAL, LLC
                                          COMMUNITY PSYCHIATRIC CENTERS OF
                                          TEXAS, INC.
                                          INDIANA PSYCHIATRIC INSTITUTES, INC.
                                          LEBANON HOSPITAL, LLC
                                          MESILLA VALLEY GENERAL PARTNERSHIP
                                          MESILLA VALLEY HOSPITAL, INC.
                                          MESILLA VALLEY MENTAL HEALTH
                                          ASSOCIATES, INC.

<PAGE>

                                          NORTHERN INDIANA HOSPITAL, LLC
                                          VALLE VISTA, LLC
                                          WILLOW SPRINGS, LLC

                                          By: /s/ W. Page Barnes
                                              ---------------------------------
                                              Name: W. Page Barnes
                                              Title: Senior Vice President

<PAGE>

The foregoing Registration Rights Agreement is hereby
confirmed and accepted as of the date first above written.

BANG OF AMERICA SECURITIES LLC
UBS SECURITIES LLC
BANC ONE CAPITAL MARKETS, INC.
MERRILL LYNCH, PIERCE, FENNER & SMITH
         INCORPORATED

By: BANC OF AMERICA SECURITIES LLC

By: /s/ Bruce Thompson
    ------------------------------
    Name:  Bruce Thompson
    Title: August 19, 2003

                                       22
<PAGE>

                                   SCHEDULE A
                              SUBSIDIARY GUARANTORS

AHS Albuquerque Holdings, LLC
AHS Albuquerque Regional Medical Center, LLC
AHS Albuquerque Physician Group, LLC
AHS Albuquerque Rehabilitation Hospital, LLC
AHS Cumberland Hospital, LLC
AHS Kentucky Holdings, Inc.
AHS Kentucky Hospitals, Inc.
AHS Louisiana Holdings, Inc.
AHS Louisiana Hospitals, Inc.
AHS Management Company, Inc.
AHS Management Services of New Jersey, LLC
AHS New Mexico Holdings, Inc.
AHS Northeast Heights Hospital, LLC
AHS Research and Review, LLC
AHS Samaritan Hospital, LLC
AHS S.E.D. Medical Laboratories, Inc.
AHS Summit Hospital, LLC
AHS West Mesa Hospital, LLC
Ardent Medical Services, Inc.
Behavioral Healthcare Corporation
BHC Alhambra Hospital, Inc.
BHC Belmont Pines Hospital, Inc.
BHC Cedar Crest RTC, Inc.
BHC Cedar Vista Hospital, Inc.
BHC Clinicas Del Este Hospital, Inc.
BHC Columbus Hospital, Inc.
BHC Fairfax Hospital, Inc.
BHC Fort Lauderdale Hospital, Inc.
BHC Fox Run Hospital, Inc.
BHC Freemont Hospital, Inc.
BHC Gulf Coast Management Group, Inc.
BHC Health Services of Nevada, Inc.
BHC Heritage Oaks Hospital, Inc.
BHC Hospital Holdings, Inc.
BHC Intermountain Hospital, Inc.
BHC Lebanon Hospital, Inc.
BHC Management Holdings, Inc.
BHC Management Services, LLC
BHC Management Services of Indiana, LLC
BHC Management Services of Kentucky, LLC
BHC Management Services of New Mexico, LLC
BHC Management Services of Pennsylvania, LLC
BHC Management Services of Streamwood, LLC
BHC Meadows Partner, Inc.
BHC Millwood Hospital, Inc.
BHC Montevista Hospital, Inc.
BHC Northwest Psychiatric Hospital, LLC
BHC of Indiana, General Partnership
BHC of Northern Indiana, Inc.

<PAGE>

BHC Pacific Gateway Hospital, Inc.
BHC Pacific Shores Hospital, Inc.
BHC Pacific View RTC, Inc.
BHC Physician Services of Kentucky, LLC
BHC Pinnacle Pointe Hospital, Inc.
BHC Properties, Inc.
BHC Ross Hospital, Inc.
BHC San Juan Capestrano Hospital, Inc.
BHC Sierra Vista Hospital, Inc.
BHC Spirit of St. Louis Hospital, Inc.
BHC Streamwood Hospital, Inc.
BHC Valle Vista Hospital, Inc.
BHC Vista Del Mar Hospital, Inc.
BHC Windsor Hospital, Inc.
Bloomington Meadows, G.P.
Columbus Hospital, LLC
Community Psychiatric Centers of Texas, Inc.
Indiana Psychiatric Institutes, Inc.
Lebanon Hospital, LLC
Mesilla Valley General Partnership
Mesilla Valley Hospital, Inc.
Mesilla Valley Mental Health Associates, Inc.
Northern Indiana Hospital, LLC
Valle Vista, LLC
Willow Springs, LLC

                                        2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00057-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00057-of-00352.parquet"}]]